Obesity increases risk of anticoagulation reversal failure with prothrombin complex concentrate in those with intracranial hemorrhage

References

• Liotta EM, Prabhakaran S. Warfarin-associated intracerebral hemorrhage is increasing in prevalence in the United States. J Stroke Cerebrovasc Dis 2013;22(7):1151–5.
   PubMed Web of Science ®Google Scholar
• Sacco S, Marini C, Toni D, et al. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke 2009;40(2):394–9.
   PubMed Web of Science ®Google Scholar
• Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians' evidence-based clinical practice guidelines. Chest 2012;141(2 Suppl):e152S-84S.
   PubMed Web of Science ®Google Scholar
• Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010;41(9):2108–29.
   PubMed Web of Science ®Google Scholar
• Baker RI, Coughlin PB, Gallus AS, et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004;181(9):492–7.
   PubMed Web of Science ®Google Scholar
• Leissinger CA, Blatt PM, Hoots WK, et al. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 2008;83(2):137–43.
   PubMed Web of Science ®Google Scholar
• Boulis NM, Bobek MP, Schmaier A, et al. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 1999;45(5):1113–18; discussion 8–9.
   PubMed Web of Science ®Google Scholar
• Chapman SA, Irwin ED, Beal AL, et al. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin. Ann Pharmacother 2011;45(7–8):869–75.
   PubMed Web of Science ®Google Scholar
• Tran HA, Chunilal SD, Harper PL, et al. An update of consensus guidelines for warfarin reversal. Med J Aust 2013;198(4):198–9.
   PubMed Web of Science ®Google Scholar
• Pabinger I, Brenner B, Kalina U, et al. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost 2008;6(4):622–31.
   PubMed Web of Science ®Google Scholar
• Riess HB, Meier-Hellmann A, Motsch J, et al. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res 2007;121(1):9–16.
   PubMed Web of Science ®Google Scholar
• Yasaka M, Sakata T, Naritomi H, et al. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res 2005;115(6):455–9.
   PubMed Web of Science ®Google Scholar
• van Aart L, Eijkhout HW, Kamphuis JS, et al. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. Thromb Res 2006;118(3):313–20.
   PubMed Web of Science ®Google Scholar
• Bershad EM, Suarez JI. Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature. Neurocrit Care 2010;12(3):403–13.
   PubMed Web of Science ®Google Scholar
• Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002;288(14):1723–7.
   PubMed Web of Science ®Google Scholar
• Cabral KP, Fraser GL, Duprey J, et al. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding. Clin Neurol Neurosurg 2013;115(6):770–4.
   PubMed Web of Science ®Google Scholar
• Hickey M, Gatien M, Taljaard M, et al. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department. Circulation 2013;128(4):360–4.
   PubMed Web of Science ®Google Scholar
• Köhler M. Thrombogenicity of prothrombin complex concentrates. Thromb Res 1999;95(4, Suppl 1):S13–7.
   PubMed Web of Science ®Google Scholar
• Baggs JH, Patanwala AE, Williams EM, et al. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal. Ann Pharmacother 2012;46(1):51–6.
   PubMed Web of Science ®Google Scholar
• Switzer JA, Rocker J, Mohorn P, et al. Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage. Stroke 2012;43(9):2500–02.
   PubMed Web of Science ®Google Scholar
• Patanwala AE, Acquisto NM, Erstad BL. Prothrombin complex concentrate for critical bleeding. Ann Pharmacother 2011;45(7–8):990–9.
   PubMed Web of Science ®Google Scholar
• Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev 2002;3(2):85–101.
   PubMedGoogle Scholar
• Jacques KA, Erstad BL. Availability of information for dosing injectable medications in underweight or obese patients. Am J Health Syst Pharm 2010;67(22):1948–50.
   PubMed Web of Science ®Google Scholar